John Scott

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

Paul M. Ridker, Jean MacFadyen, Tom Thurén et al. · The Lancet · 2017 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +13

Effects of Lowering Average or Below-Average Cholesterol Levels on the Progression of Carotid Atherosclerosis

Stephen MacMahon, Norman Sharpe, Greg Gamble et al. · Circulation · 1998 · 264 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease

Stephen MacMahon, Norman Sharpe, Greg Gamble et al. · Journal of the American College of Cardiology · 2000 · 235 citations

Medicine, Cardiology, Pharmacology +11

Helical CT versus EUS with fine needle aspiration for celiac nodal assessment in patients with esophageal cancer

Joseph Romagnuolo, John Scott, Robert H. Hawes et al. · Gastrointestinal Endoscopy · 2002 · 106 citations

Medicine, Oncology, Radiology +10

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15